The influence of open arm ledges and maze experience in the elevated plus-maze

Pharmacology Biochemistry and Behavior

Volumn 54, Issue 1, 1996, Pages 31-40

  Fernandes, Cathy ^a   File, Sandra E ^a  

^a GUY S HOSPITAL   (United Kingdom)

Author keywords

anxiety; benzodiazepines; factor analysis; holeboard; motor activity; phobia; plus maze

Indexed keywords

ANXIOLYTIC AGENT; CHLORDIAZEPOXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; CONFERENCE PAPER; CONTROLLED STUDY; ETHOLOGY; EXPERIENCE; EXPLORATORY BEHAVIOR; FACTORIAL ANALYSIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MAZE TEST; METHODOLOGY; MOTOR ACTIVITY; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0029968928     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(95)02171-X     Document Type: Conference Paper

References (21)

1. Blanchard, R. J.; Blanchard, D. C. Anti-predator defensive behaviors in a visible burrow system. J. Comp. Psychol. 103:70-82; 1989.
2. Blanchard, R. J.; Parmigiani, S.; Bjornson, C.; Masuda, C.; Weiss, S. M.; Blanchard, D. C. Anti-predator behavior of Swiss-Webster mice in a visible burrow system. Aggress. Behav. 21:123-136; 1995.
3. Bond, A.; Lader, M. H. The use of analogue scales in rating subjective feelings. Br. J. Med. Psychol. 47:211-218; 1974.
4. Cruz, A. P. M.; Frei, F.; Graeff, F. G. Ethopharmacological analysis of rat behavior on the elevated plus-maze. Pharmacol. Biochem. Behav. 49:171-176; 1994.
5. Dawson, G. R.; Crawford, S. P.; Stanhope, K. J.; Iversen, S. D.; Tricklebank, M. D. One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology (Berlin) 113:570-572; 1994.
6. File, S. E. One-trial tolerance to the anxiolytic effects of chlordiazepoxide in the plus-maze. Psychopharmacology (Berlin) 100: 281-282; 1990.
7. File, S. E. The biological basis of anxiety. In: Meltzer, H. Y.; Nerozzi, D., eds. Current practices and future developments in the pharmacotherapy of mental disorders. New York: Elsevier Science; 1991:159-165.
8. File, S. E. Behavioural detection of anxiolytic action. In: Elliott, J. M.; Heal, D. J.; Marsden, C. A., eds. Experimental approaches to anxiety and depression. London: John Wiley & Sons Ltd.; 1992:25-44.
9. File, S. E. The interplay of learning and anxiety in the elevated plus-maze. Behav. Brain Res. 58:199-202; 1993.
10. File, S. E.; Wardill, A. G. The reliability of the holeboard apparatus. Psychopharmacologia 44:47-51; 1975.
11. File, S. E.; Mabbutt, P. S.; Hitchcott, P. Characterisation of the phenomenon of "one-trial tolerance" to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze. Psychopharmacology (Berlin) 102:98-101; 1990.
12. File, S. E.; Zangrossi, H., Jr.; Viana, M.; Graeff, F. G. Trial 2 in the elevated plus-maze: A different form of fear? Psychopharmacology (Berlin) 111:491-494; 1993.
13. Handley, S. L.; Spooner, H. A.; McCreary, A. C.; McBlane, J. W. Factor analysis of behaviour in the elevated x maze. J. Psychopharmacol. 9:A32; 1995.
14. Hogg, S. Validity and variability of the elevated plus-maze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54(1):21-30; 1996.
15. Jones, G. H.; Cole, B. J. Are drug effects in the plus-maze dependent on the baseline level of fear? Behav. Pharmacol. 5:87; 1994.
16. Lister, R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 92:180-185; 1987.
17. Pellow, S.; Chopin, P.; File, S. E.; Briley, M. Validation of open : closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods 14:149-167; 1985.
18. Rodgers, R. J.; Johnson, N. J. T. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol. Biochem. Behav. 52:297-303; 1995.
19. Rodgers, R. J.; Lee, C.; Shepherd, J. K. Effects of diazepam on behavioural and antinociceptive responses to the elevated plus-maze in male mice depend upon treatment regimen and prior maze experience. Psychopharmacology (Berlin) 106:102-110; 1992.
20. Treit, D.; Menard, J.; Royan, C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol. Biochem. Behav. 44:463-469; 1993.
21. Trullas, R.; Winslow, T. R.; Insel, T. R.; Skolnick, P. Are glutamatergic pathways involved in the pathophysiology of anxiety? In: Briley, M.; File, S. E., eds. New concepts in anxiety. New York: Macmillan; 1991:382-394.